VEGF Scaffolds Enhance Angiogenesis and Bone Regeneration in Irradiated Osseous Defects
Top Cited Papers
Open Access
- 1 May 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 21 (5) , 735-744
Abstract
Bone regeneration is challenging in sites where the blood supply has been compromised by radiation. We examined the potential of a growth factor (VEGF) delivery system to enhance angiogenesis and bone formation in irradiated calvarial defects. VEGF-releasing polymers significantly increased blood vessel density and vascular perfusion in irradiated defects and increased bone formation relative to control conditions. Introduction: Radiation therapy causes damage to tissues and inhibits its regenerative capacity. Tissue injury from radiation is in large part caused by a compromised vascular supply and reduced perfusion of tissues. The aim of this study was to determine if delivery of vascular endothelial growth factor (VEGF) from a biodegradable PLGA (copolymer of d,l-lactide and glycolide) scaffold could enhance neovascularization and bone regeneration in irradiated osseous defects. Materials and Methods: An isolated area of the calvarium of Fisher rats was irradiated (12 Gy) 2 weeks preoperatively, and two 3.5-mm osseous defects were created in this area, followed by the placement of PLGA scaffolds or VEGF scaffolds (PLGA scaffolds with incorporated VEGF) into the defects. Laser Doppler perfusion imaging was performed to measure perfusion of these areas at 1, 2, and 6 weeks. Implants were retrieved at 2, 6, and 12 weeks, and histologic and μCT analyses were performed to determine neovascularization and bone regeneration. Results: Histological analyses revealed statistically significant increases in blood vessel formation (>2-fold) and function (30%) within the VEGF scaffolds compared with PLGA scaffolds. Additionally, evaluation of bone regeneration through bone histomorphometric and μCT analyses revealed significantly greater bone coverage (26.36 ± 6.91% versus 7.05 ± 2.09% [SD]) and increased BMD (130.80 ± 58.05 versus 71.28 ± 42.94 mg/cm3) in VEGF scaffolds compared with PLGA scaffolds. Conclusions: Our findings show that VEGF scaffolds have the ability to enhance neovascularization and bone regeneration in irradiated osseous defects, outlining a novel approach for engineering tissues in hypovascular environments.Keywords
This publication has 42 references indexed in Scilit:
- Bone Regeneration in Cranial Defects Previously Treated with RadiationThe Laryngoscope, 2005
- Endothelial cell modulation of bone marrow stromal cell osteogenic potentialThe FASEB Journal, 2005
- Estrogen Regulates the Production of VEGF for Osteoclast Formation and Activity in op/op MiceJournal of Bone and Mineral Research, 2004
- Ex Vivo Gene Therapy for Skeletal Regeneration in Cranial Defects Compromised by Postoperative RadiotherapyHuman Gene Therapy, 2003
- Synergistic enhancement of bone formation and healing by stem cell–expressed VEGF and bone morphogenetic protein-4Journal of Clinical Investigation, 2002
- Gene Therapy-Directed Osteogenesis: BMP-7-Transduced Human Fibroblasts Form Bone in VivoHuman Gene Therapy, 2000
- Evaluation of the long-term effect of function on rhBMP-2 regenerated hemimandibulectomy defectsBritish Journal of Oral and Maxillofacial Surgery, 1999
- Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitroMolecular and Cellular Endocrinology, 1997
- Repair of Calvarial Defects with Flap Tissue: Role of Bone Morphogenetic Proteins and Competent Responding TissuesPlastic and Reconstructive Surgery, 1996
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989